| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |